NCCN Updates Ovarian Cancer GuidelinesAnis unavailable. This article is available as HTML full text and PDF.doi:10.1097/01.COT.0000397191.46574.8bSusmanEdOncology Times
The National Comprehensive Cancer Network (NCCN) guidelines recommend selective resection of all peritoneal surfaces and any metastatic lymph nodes suspected of harboring cancer, as this approach aims to enhance survival rates. Currently, the diagnosis of metastatic lesions primarily relies on laparoscopy,...
NCCN Guidelines® insights: ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022;20(9):972–80. Article PubMed Google Scholar Hu D, Ma D, Zhang ZJ, Zhang Y, Huang K, Li X. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: a...
To me, what I like about the NCCN guidelines is that they say you can use bevacizumab however you want to, basically, in upfront ovarian cancer. We really need to be testing these folks, and we should stratify based off of testing. It’s taking all the data that we’ve discussed and...
NCCN Guidelines® insights: ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022;20(9):972–80. Article PubMed Google Scholar Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, et al. Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy...
Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and is initially very responsive to platinum-based chemotherapy. However, the majority of patients relapse following initial surgery and chemotherapy, highlighting the urgent need to develop new therapeutic strategies. ...
D. E. Wood, "National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening," Thoracic Surgery Clinics, vol. 25, no... Wood,E Douglas - 《Thoracic Surgery Clinics》 被引量: 369发表: 2015年 National Comprehensive Cancer Network (NCCN) Clinical Practice Guide...
Armstrong, D. K. et al. NCCN Guidelines® Insights: ovarian cancer, version 3.2022.J. Natl Compr. Canc. Netw.20, 972–980 (2022). ArticlePubMedGoogle Scholar Konstantinopoulos, P. A. et al. Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline.J. Clin. Onco...
Epithelial ovarian cancer (EOC) is a deadly disease with limited diagnostic biomarkers and therapeutic targets. Here we conduct a comprehensive proteomic profiling of ovarian tissue and plasma samples from 813 patients with different histotypes and thera
Epithelial ovarian cancer (EOC) is a deadly disease with limited diagnostic biomarkers and therapeutic targets. Here we conduct a comprehensive proteomic profiling of ovarian tissue and plasma samples from 813 patients with different histotypes and thera